Inspiring Innovations: The Impact of the MOASC Young Investigator Award

The MOASC represents a prestigious accolade designed to recognize and encourage promising young researchers in the field of oncology. This award seeks to highlight individuals who have demonstrated exceptional potential through their innovative research, contributions to oncology, and commitment to advancing cancer care. Awardees are selected based on the novelty, impact, and scientific merit of their work, showcasing groundbreaking findings that could lead to significant advancements in the diagnosis, treatment, and understanding of cancer. The recognition not only celebrates the achievements of these emerging leaders in oncology but also aims to foster their career development, providing support and visibility within the scientific community. Through this initiative, MOASC underscores its commitment to nurturing the next generation of oncology researchers, ensuring continued progress in the fight against cancer.

Salvador Jaime Casas, MD Post-Doctoral Fellow City of Hope examines the impact of insurance payer status on the overall survival and practice patterns in patients with metastatic urothelial carcinoma, highlighting that Medicare patients, especially those with secondary coverage, show significantly greater survival compared to those with private insurance or Medicaid/uninsured status.

Megan Wong – City of Hope examines adherence to the American Society of Clinical Oncology’s Language of Respect guidelines in prostate cancer abstracts from the 2022 ASCO Annual Meeting, revealing that a significant portion of abstracts contained statements non-compliant with these guidelines, particularly from authors affiliated with non-native English-speaking institutions.

Jaya Goud of City of Hope evaluates the adherence to ASCO’s Language of Respect guidelines in renal cell carcinoma abstracts presented at the 2023 ASCO Annual Meeting, revealing significant non-compliance, and emphasizes the need for multilingual dissemination and greater awareness to ensure respectful and patient-centered communication in scientific discourse.

Benjamin Mercier Clinical Research Assistant City of Hope presents a study on the adherence to ASCO’s Language of Respect (LoR) guidelines within urothelial carcinoma abstracts at the 2023 ASCO Annual Meeting, revealing that a significant portion did not comply, especially those from non-native English-speaking countries, underscoring the need for broader educational efforts.